☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
Noven’s Xelstrym (dextroamphetamine) Transdermal System Receives the US FDA’s Approval for the Treatment of ADHD
March 23, 2022
GSK Entered into a R&D Collaboration with LifeMine to Discover Novel Therapies for Multiple Disease
March 23, 2022
Palisade Bio Receives the US FDA’s Study May Proceed Letter for P-III Clinical Trial of LB1148 to Improved Bowel Function After Ab...
March 23, 2022
Novavax and Serum Institute of India’s NVX-CoV2373 Receives the DCGI's EUA for the Treatment of COVID-19 in Adolescents Aged ≥12 t...
March 23, 2022
Aligos Discontinues ALG-020572 in the (ALG-020572-401) Study for the Treatment of Chronic Hepatitis B
March 23, 2022
BioMarin’s Vimizin (elosulfase alfa) Receives NICE Recommendation for the Treatment of Mucopolysaccharidosis Type 4A
March 23, 2022
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions